SCHEMBL20956423

SCHEMBL20956423

Cc1ccc(C=NN(C)c2nc(-c3ccccc3Cl)cs2)c(C(=O)O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19631428 1.00 DHODH (1.00) DHODH
SCHEMBL29859593 1.00 DHODH (1.00) DHODH
SCHEMBL20842872 0.93 DHODH (0.86) DHODH
SCHEMBL21393927 0.90 DHODH (0.82) DHODH
SCHEMBL24142242 0.90 DHODH (0.84) DHODH
SCHEMBL28343272 0.90 DHODH (1.00) DHODH
SCHEMBL24861294 0.90 DHODH (0.81) DHODH
SCHEMBL19631429 0.90 DHODH (1.00) DHODH
SCHEMBL29859506 0.90 DHODH (1.00) DHODH
SCHEMBL20836131 0.89 DHODH (1.00) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) 2023-02-28 — — US disclosed
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-12-27 — — US disclosed
CN-107375279-B Use of novel thiazole derivatives for the treatment of inflammatory bowel disease 华东理工大学 2022-11-01 — — CN disclosed
CN-107382902-B Thiazole derivative and application thereof 华东理工大学 2022-08-12 — — CN disclosed
CN-107459496-B Use of thiazole derivatives for treating viral infections 华东理工大学 2022-07-19 — — CN disclosed
US-10919869-B2 Thiazole derivative and applications EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-02-16 — — US disclosed
CN-106892878-B Thiazole derivative and application thereof in inhibiting dihydroorotate dehydrogenase 华东理工大学 2020-01-10 — — CN disclosed
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases FABP2, SLC10A2, ALPI DHODH 803/4885
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS DHODH, DLD, THOC2 DHODH 1/4885
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES FABP2, SLC10A2, ALPI DHODH 803/4885
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885
US-10919869-B2 Thiazole derivative and applications DHODH, DLD, THOC2 DHODH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback